Recent Advances in Innovative Magnetic Nanomaterials for Cancer Theranostics

Description

In this book, cancer theranostics applications of magnetic iron oxide nanoparticles are overviewed in details. Moreover, their synthesis, characterization, multifunctionality, disease targeting, biodistribution, pharmacokinetics and toxicity have been briefly highlighted. Finally, we have mentioned the current examples of clinical trials of magnetic nanoparticles in cancer theranostics along with their future scopes and challenges. PRELIMS.pdf Preface Acknowledgments Funding Conflicts of interest Author biography Sudip Mukherjee CH001.pdf Chapter 1 Introduction 1.1 Cancer and statistics 1.2 Conventional therapies for cancer and their limitations 1.3 Alternative theranostics strategy: nanomedicine 1.4 Magnetic nanoparticles and cancer theranostics References CH002.pdf Chapter 2 Magnetic iron oxide nanoparticles: types, synthesis and characterization 2.1 Common types of magnetic nanomaterials and their synthesis 2.2 Characterization techniques 2.3 Multilayer concept References CH003.pdf Chapter 3 Magnetic nanoparticles for cancer diagnostics 3.1 MRI 3.2 Multimodal imaging 3.3 Biosensors 3.4 Cell labeling and monitoring of cancer treatments References CH004.pdf Chapter 4 Magnetic iron oxide based nanoparticles for cancer therapeutics 4.1 Drug delivery 4.1.1 Chemotherapeutics 4.1.2 Biotherapeutics 4.1.3 Radiotherapeutics 4.2 Magnetic hyperthermia 4.3 Photothermal ablation 4.4 Photodynamic therapy (PDT) 4.5 MNPs as anti-cancer agent 4.6 MNPs in cancer immunotherapy References CH005.pdf Chapter 5 Safety of magnetic iron oxide nanomaterials, challenges, future scope and conclusion 5.1 Pharmacokinetics, biodistribution, toxicity 5.2 Targeting 5.3 Magnetic nanoparticles as FDA approved or in clinical trials 5.4 Challenges, future scopes and conclusion References